Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Vaxem-Hib in Korean Children
NCT01404962Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2011
- Primary completion
- Jul 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of VaxemHIB in Haemophilus influenzae type b infection (Hib), sponsored by Novartis. Started Aug 2011; status: completed.
02
Drugs
VaxemHIB
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01404962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404962.